Our Mission at Duke’s Cardiovascular and Pulmonary Physical Therapy is to provide an in-depth experience in the management of cardiovascular and pulmonary conditions across the continuum of care.
What Makes Our Program Unique
Being a resident of our program gives you access to some of the top medical professionals in the nation. Our doctors are providing interesting treatments meaning you’ll have the opportunity to work with unique patients you wouldn’t see elsewhere.
This includes working closely with:
- Heart and lung transplants
- Ventricular assist devices
- Patients being ambulated while receiving extracorporeal membrane oxygenation
- Patients who are exercising with a femoral intra-aortic balloon pump
- Patients being ambulated with an axillary intra-aortic balloon pump
- Early mobility interventions with patients on ventilators
Highlights of Our Program
The Duke Cardiovascular and Pulmonary Residency program offers residents clinical exposure in both the inpatient acute care setting and outpatient rehab. This unique combination of clinical rotations affords our residents the ability to see many cardiopulmonary diagnoses across the continuum of care.
Our inpatient setting includes two months in each of the following areas: cardiology and cardiac ICU, pulmonology and medical ICU, and the cardiothoracic step-down unit and ICU.
The outpatient pulmonary rehab setting includes two months in the following units: lung transplant, pulmonary rehabilitation, and cardiac rehabilitation.
Beyond our clinical experience, Duke is part of many cardiopulmonary research studies including nationwide and multi-center research projects. Our residents work closely with research teams to complete the required research component of the program.
How to Apply
Anyone with a strong desire to work in cardiovascular and pulmonary physical therapy should apply.
Applications open October 1st, 2023. Interested individuals can fill out an application via RF-PTCAS to apply. All applications for the 2024 – 2025 residency are due by December 1, 2023.